AI
Tuesday, July 13, 2010 9:11:29 AM
VVUS up in pre-market: “In a review posted to its Web site Tuesday, U.S. drug regulators said Vivus'(VVUS) weight-loss drug Qnexa was effective in helping obese patients shed pounds, but the agency raised questions -- most of them expected -- about the drug's safety.”
There is still hope…even for fat people…
There is still hope…even for fat people…
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
